CANNAPHARMARX, INC. (CPMD) › Shareholders' EquityCANNAPHARMARX, INC. (CPMD) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: -$576.3K2010: $1002011: -$99.6K2012: -$197.6K2013: -$292.0K2014: -$288.2K2015: -$684.5K2016: -$957.7K2017: -$964.3K2018: -$286.3K2019: $4.85M2020: -$8.80M2021: -$12.93M2022: $17.34M2023: -$12.15M2024: -$19.81M2025: -$30.15M-$30.15M2009Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$30.15M-52.2%2024-$19.81M-63.0%2023-$12.15M-170.1%2022$17.34M+234.2%2021-$12.93M-46.9%2020-$8.80M-281.3%2019$4.85M+1795.5%2018-$286.3K+70.3%2017-$964.3K-0.7%2016-$957.7K-39.9%2015-$684.5K-137.5%2014-$288.2K+1.3%2013-$292.0K-47.8%2012-$197.6K-98.5%2011-$99.6K-99661.0%2010$100+100.0%2009-$576.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share